Verrica Pharmaceuticals (VRCA) Competitor Comparison
We are evaluating the key criteria listed to compare Verrica Pharmaceuticals (VRCA) against its competitors in the Biotechnology industry.
Market Capitalization
215 / 368Gross Profits
103 / 278Total Revenue
214 / 300EBITDA
135 / 337Free Cashflow
109 / 352Quick Ratio
118 / 357Earnings per Share
197 / 359Dividend yield
0 / 6Total Cash
230 / 358Performance 3 years
284 / 368Performance 5 years
271 / 368Performance 10 years
264 / 368Linearity 3 years
201 / 368Linearity 5 years
198 / 367Linearity 10 years
177 / 368Total Rank
57 / 368Dividend Rank
303 / 368Valuation Rank
172 / 368Piotroski Rank
318 / 368Muliplier Rank
230 / 368Performance 3 years - VRCA ranking 284 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.